These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23100457)

  • 1. Possible reinforcement enhancing effects of bupropion during initial smoking abstinence.
    Perkins KA; Karelitz JL; Jao NC; Stratton E
    Nicotine Tob Res; 2013 Jun; 15(6):1141-5. PubMed ID: 23100457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reinforcement Enhancing Effects of Nicotine Via Patch and Nasal Spray.
    Perkins KA; Karelitz JL; Boldry MC
    Nicotine Tob Res; 2019 May; 21(6):778-783. PubMed ID: 29514317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of stress and bupropion on craving, withdrawal symptoms, and mood in smokers.
    Kotlyar M; Drone D; Thuras P; Hatsukami DK; Brauer L; Adson DE; al'Absi M
    Nicotine Tob Res; 2011 Jun; 13(6):492-7. PubMed ID: 21378081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bupropion on cognitive performance during initial tobacco abstinence.
    Perkins KA; Karelitz JL; Jao NC; Gur RC; Lerman C
    Drug Alcohol Depend; 2013 Nov; 133(1):283-6. PubMed ID: 23726977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of bupropion on nicotine craving and withdrawal.
    Shiffman S; Johnston JA; Khayrallah M; Elash CA; Gwaltney CJ; Paty JA; Gnys M; Evoniuk G; DeVeaugh-Geiss J
    Psychopharmacology (Berl); 2000 Jan; 148(1):33-40. PubMed ID: 10663415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bupropion. An antidepressant used to help smoking cessation].
    Taeron C
    Rev Infirm; 2002 May; (81):47-9. PubMed ID: 12078615
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of bupropion on physiological measures of stress in smokers during nicotine withdrawal.
    Kotlyar M; Brauer LH; al'absi M; Adson DE; Robiner W; Thuras P; Harris J; Finocchi ME; Bronars CA; Candell S; Hatsukami DK
    Pharmacol Biochem Behav; 2006 Mar; 83(3):370-9. PubMed ID: 16581115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of sustained-release bupropion and placebo for smoking cessation.
    Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM
    N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for smoking cessation and reduction in individuals with schizophrenia.
    Tsoi DT; Porwal M; Webster AC
    Cochrane Database Syst Rev; 2010 Jun; (6):CD007253. PubMed ID: 20556777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressants for smoking cessation.
    Howes S; Hartmann-Boyce J; Livingstone-Banks J; Hong B; Lindson N
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD000031. PubMed ID: 32319681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial.
    Tashkin D; Kanner R; Bailey W; Buist S; Anderson P; Nides M; Gonzales D; Dozier G; Patel MK; Jamerson B
    Lancet; 2001 May; 357(9268):1571-5. PubMed ID: 11377644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion: a review of its use in the management of smoking cessation.
    Holm KJ; Spencer CM
    Drugs; 2000 Apr; 59(4):1007-24. PubMed ID: 10804045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2005 Nov; 183(1):1-12. PubMed ID: 16160876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential sex differences in the pattern of sensory reinforcers enhanced by nicotine.
    Perkins KA; Karelitz JL
    Exp Clin Psychopharmacol; 2016 Jun; 24(3):156-61. PubMed ID: 27124265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bupropion smoking cessation clinical trial for cancer patients.
    Schnoll RA; Martinez E; Tatum KL; Weber DM; Kuzla N; Glass M; Ridge JA; Langer C; Miyamoto C; Wileyto EP; Leone F
    Cancer Causes Control; 2010 Jun; 21(6):811-20. PubMed ID: 20087643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence.
    Perkins KA; Karelitz JL; Michael VC; Fromuth M; Conklin CA; Chengappa KN; Hope C; Lerman C
    Nicotine Tob Res; 2016 Jan; 18(1):74-8. PubMed ID: 25895948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications.
    Perkins KA; Lerman C; Karelitz JL; Jao NC; Chengappa KN; Sparks GM
    Addiction; 2013 Nov; 108(11):1962-8. PubMed ID: 23773319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.